This is supported by studies conducted in a mouse model, which demonstrated that blocking VEGFR-3 signaling using fusion proteins that act as VEGF-C’s traps reduced tumor lymphangiogenesis and lymphatic dispersion [12, 13]. The gene discussed is FLT4; the disease is neoplasm.